IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,427,389 | -31.2% | 67,918 | -27.3% | 0.06% | -6.6% |
Q4 2022 | $3,529,040 | -48.1% | 93,435 | -39.2% | 0.06% | -47.4% |
Q3 2022 | $6,795,000 | +93.0% | 153,636 | +74.0% | 0.12% | +81.2% |
Q2 2021 | $3,521,000 | +42.9% | 88,273 | +61.1% | 0.06% | +52.4% |
Q1 2021 | $2,464,000 | – | 54,804 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |